Map Pharma (MAPP) Shares Now Down 30%
After an initial move slightly lower, shares of Map Pharma (Nasdaq: MAPP) are now down more than 30 percent in Tuesday's pre-open session. The last traded was at $11.50.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Level 3 Communications (LVLT) to Replace Jabil Circuit (JBL) in S&P 500
- Kapstone (KS) Taps Advisors to Evaluate MLP - Conf. Call
- American Realty Capital Properties (ARCP) Announces non-Reliance of Certain Financial Statements
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!